// App-Quantinova.ai

TCT-742 : Individual and Regional Variations in Dual Antiplatelet Therapy Dose and Duration in a Large, Randomized International Trial Comparing Two Drug-eluting Stents: Results From PROTECT

Researchers

Presenter

  • Laura Mauri

Principal Investigators

  • Gabriel Steg

  • Alexis Matteau

  • Edoardo Camenzind

  • Eric Boersma

  • Pascal Vranckx

  • Patrick Serruys

  • William -Neill

  • Robert Yeh

  • William Wijns

Medical Centers

  • Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, United States

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Cardiovascular Center Aalst, Belgium, Aalst, Belgium

  • Hopital Bichat, Paris, France, Paris, France

  • Hartcentre Hasselt, Hasselt, Belgium

  • University Hospital Geneva, Geneva, Switzerland

  • Brigham and Women's Hospital, Brookline, MA

Locations

  • Netherlands

  • Switzerland

  • United States

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • ZoMaxx

  • Clopidogrel bisulfate

  • Rapacan

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved